On this page
MFSD8
major facilitator superfamily domain containing 8
The MFSD8 gene provides instructions for a protein thought to be involved in transporting molecules across lysosomal membranes, playing a role in cellular waste recycling. The MFSD8 gene encodes a protein that is a member of the major facilitator superfamily of secondary active transporters.
MFSD8 is located on the long (q) arm of chromosome 4, at band 4q28.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 4 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The MFSD8 gene, full name major facilitator superfamily domain containing 8, provides instructions for creating the MFSD8 protein. This protein is integral to the membranes of lysosomes, which are cellular compartments responsible for breaking down and recycling various molecules. The MFSD8 protein belongs to a large family of transporter proteins, suggesting its role involves moving specific substances across membranes, though the exact molecules it transports are yet to be identified.
What the gene does
The MFSD8 protein is hypothesised to function as a transporter, facilitating the movement of molecules across the lysosomal membrane. Lysosomes are essential organelles involved in the degradation of cellular waste products, and their proper function is critical for maintaining cellular health. As a member of the major facilitator superfamily, the MFSD8 protein likely moves specific molecules within or between cellular compartments, though its precise substrates have not been identified. Its presence within the lysosomal membrane points to a key role in the dynamic processes of cellular recycling and waste management.
Video: Genetics 101
Chromosome location
The MFSD8 gene is located on chromosome 4, specifically at position 4q28.2. This genomic address specifies its precise physical location on the long arm (q) of chromosome 4. The gene contains multiple exons, which are the protein-coding regions that are ultimately translated into the MFSD8 protein.
Protein structure
The MFSD8 protein consists of 518 amino acids. It features a Disordered region spanning amino acids 1-20, which often indicates flexibility or involvement in protein-protein interactions. Additionally, a Dileucine internalization motif is present at amino acids 13-14, which is typically involved in targeting proteins to specific cellular compartments or regulating their internalisation.
Key variants
Genetic variations within the MFSD8 gene can alter the protein's structure and function. These changes may lead to impaired lysosomal activity, affecting the cell's ability to process and recycle waste materials. Research continues to identify and characterise the range of MFSD8 variants and their impact on protein function.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1102+2T>C | - | Pathogenic/Likely pathogenic | ★★☆☆ | Late-infantile neuronal ceroid lipofuscinosis |
c.1158_1167del | p.Trp387fs | Pathogenic/Likely pathogenic | ★★☆☆ | Late-infantile neuronal ceroid lipofuscinosis |
c.1337del | p.Gly446fs | Pathogenic/Likely pathogenic | ★★☆☆ | Late-infantile neuronal ceroid lipofuscinosis |
c.1412del | p.Phe471fs | Pathogenic/Likely pathogenic | ★★☆☆ | Late-infantile neuronal ceroid lipofuscinosis |
c.531_537del | p.Gly179fs | Pathogenic/Likely pathogenic | ★★☆☆ | Neuronal ceroid lipofuscinosis 7 |
c.593_594del | p.Val198fs | Pathogenic/Likely pathogenic | ★★☆☆ | MFSD8-related disorders |
c.600G>A | p.Trp200Ter | Pathogenic | ★★☆☆ | Neuronal ceroid lipofuscinosis 7 |
c.77T>G | p.Leu26Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Macular dystrophy with central cone involvement |
c.910C>T | p.Gln304Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Macular dystrophy with central cone involvement |
c.979del | p.Val327fs | Pathogenic | ★★☆☆ | Late-infantile neuronal ceroid lipofuscinosis |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the MFSD8 gene are associated with inherited conditions, primarily Batten disease, specifically known as CLN7 disease. This condition is characterised by progressive neurodegeneration and typically manifests in early childhood with symptoms such as developmental regression, seizures, motor skill difficulties, and vision loss.
UK clinical status
The MFSD8 gene is included in several UK NHS national genomic testing panels. It is evaluated within panels for Ataxia and cerebellar anomalies - childhood onset, Early onset or syndromic epilepsy, Hereditary ataxia (adult onset), Intellectual disability, and Retinal disorders. It is also part of panels for conditions like DDG2P, Likely inborn error of metabolism (R98), Lysosomal storage disorder (R276), Neuronal ceroid lipofuscinosis (R231), and Undiagnosed metabolic disorders, indicating its clinical significance in these areas.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the function of the MFSD8 protein?
The MFSD8 protein is a membrane-bound protein located in lysosomes, which are cellular recycling centres. While its specific cargo is unknown, it is believed to transport molecules across the lysosomal membrane, playing a role in waste processing.
What conditions are associated with MFSD8 gene variants?
Variants in the MFSD8 gene are primarily associated with CLN7 disease, a form of Batten disease. This is a severe neurodegenerative disorder that typically begins in early childhood.
How is MFSD8 related to lysosomal storage disorders?
The MFSD8 protein is crucial for proper lysosomal function. When variants disrupt its activity, it can lead to the accumulation of waste products within lysosomes, a hallmark of lysosomal storage disorders like CLN7 disease.
References
- Steenhuis P, Froemming J, Reinheckel T. Proteolytic cleavage of the disease-related lysosomal membrane glycoprotein CLN7. Biochimica et biophysica acta. 2012. PMID: 22668694
- Sharifi A, Kousi M, Sagné C. Expression and lysosomal targeting of CLN7, a major facilitator superfamily transporter associated with variant late-infantile neuronal ceroid lipofuscinosis. Human molecular genetics. 2010. PMID: 20826447
- Kousi M, Siintola E, Dvorakova L. Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis. Brain : a journal of neurology. 2009. PMID: 19201763
- Siintola E, Topcu M, Aula N. The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter. American journal of human genetics. 2007. PMID: 17564970